Application 090134
- Type
- ANDA
- Sponsor
- ACTAVIS ELIZABETH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | TABLET, DELAYED RELEASE;ORAL | EQ 75MG BASE | No | No |
| 002 | DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | TABLET, DELAYED RELEASE;ORAL | EQ 100MG BASE | No | No |
| 003 | DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | TABLET, DELAYED RELEASE;ORAL | EQ 50MG BASE | No | No |
| 004 | DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | TABLET, DELAYED RELEASE;ORAL | EQ 200MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0591-4550 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-4550 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-4550 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-4575 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-4575 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
| 0591-4575 | Doxycycline Hyclate | Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 54007 | SUPPL | 2018-05-03 |